Medical Equipment, Supplies & Distribution
Tandem Diabetes Care Inc:Expects FY 2014 sales to be in the range of $48.0 --$54.0 mln.FY 2014 revenue of $51.2 mln - Thomson Reuters I/B/E/S.
Cerus Corp:Says company's annual revenue guidance of $38-$40 million for FY 2014.FY 2014 revenue of $38.61 mln - Thomson Reuters I/B/E/S.
FDA advisory committee panel provides favorable recommendation on Baxter International Inc's HyQvia for primary immunodeficiency
Baxter International Inc and Halozyme Therapeutics, Inc:Says Blood Products Advisory Committee (BPAC) of U.S. Food and Drug Administration (FDA) voted 15-1 that HyQvia [Immune Globulin Infusion 10 pct (Human) with Recombinant Human Hyaluronidase].Says Baxter's investigational subcutaneous treatment...
DENTSPLY International Inc:Says remain comfortable with FY 2014 adjusted EPS guidance of $2.47 to $2.55 per diluted share.FY 2014 EPS of $2.52 - Thomson Reuters I/B/E/S.
No related earnings announcements are currently scheduled within the next 7 days.